Page last updated: 2024-11-03

propofol and Leukocyte Disorders

propofol has been researched along with Leukocyte Disorders in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Leukocyte Disorders: Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, SC1
Chung, PJ1
Ho, CM1
Kuo, CY1
Hung, MF1
Huang, YT1
Chang, WY1
Chang, YW1
Chan, KH1
Hwang, TL1

Other Studies

1 other study available for propofol and Leukocyte Disorders

ArticleYear
Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1.
    Journal of immunology (Baltimore, Md. : 1950), 2013, Jun-15, Volume: 190, Issue:12

    Topics: Chemotaxis, Leukocyte; Humans; Hypnotics and Sedatives; Immune System Diseases; Immunoblotting; Leuk

2013